Turning Point Therapeutics, Inc. TPTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

1/7 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 Turning Point Therapeutics, Inc. (TPTX), 包括 18 笔买入 和 26 笔卖出. 内部人买入总额为 $5.13M 内部人卖出总额为 $22.97M.

近期活跃的重要内部人包括 Machado Patrick, Gallagher Carol Giltner, Alles Mark J. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — TPTX

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2022-08-17	Machado Patrick	Director	股份退回	30,000	-	-	-
2022-08-17	Gallagher Carol Giltner	Director	股份退回	30,000	$39.99	$1.2M	-
2022-08-17	Alles Mark J	Director	股份退回	209	-	-	-
2022-08-17	Countouriotis Athena	President & CEO	股份退回	224,640	$37.68	$8.46M	-
2022-08-17	George Simeon	Director	股份退回	8,500	-	-	-
2022-08-17	Nicholson Garry A	Director	股份退回	8,500	$65.64	$557.94K	-
2022-08-17	Hirmand Mohammad	EVP and Chief Medical Officer	股份退回	41,284	$76.00	$3.14M	-
2022-08-17	Tombesi Paolo	EVP & Chief Financial Officer	股份退回	29,778	$76.00	$2.26M	-
2022-08-17	Bodem Barbara W.	Director	股份退回	14,995	$94.59	$1.42M	-
2022-08-17	Sun Brian	SVP & General Counsel	股份退回	45,000	$76.00	$3.42M	-
2022-08-17	Sabus Steve M	SVP & Chief Commercial Officer	股份退回	165,000	-	-	-
2022-07-27	Tombesi Paolo	EVP & Chief Financial Officer	知情卖出	1,183	$74.94	$88.65K	28,700
2022-05-31	Sabus Steve M	Officer	未知	-	-	-	-
2022-05-31	Sabus Steve M	SVP & Chief Commercial Officer	限制性股票授予 (RSU)	165,000	-	-	165,000
2022-04-11	Sun Brian	Officer	未知	-	-	-	-
2022-04-11	Sun Brian	SVP & General Counsel	限制性股票授予 (RSU)	195,000	-	-	195,000
2022-02-09	North Annette	EVP & General Counsel	知情卖出	669	$36.30	$24.28K	11,696
2022-02-09	Reich Siegfried	EVP & Chief Scientific Officer	知情卖出	397	$36.30	$14.41K	3,448
2022-02-09	Countouriotis Athena	President & CEO	知情卖出	2,971	$36.30	$107.85K	47,930
2022-02-09	Hirmand Mohammad	EVP & Chief Medical Officer	知情卖出	669	$36.30	$24.28K	6,838
2022-02-09	Tombesi Paolo	EVP & Chief Financial Officer	限制性股票授予 (RSU)	16,283	-	-	29,883
2022-02-09	Partridge Andrew John	EVP & Chief Commercial Officer	知情卖出	221	$36.30	$8.02K	22,078
2021-08-30	North Annette	EVP, General Counsel & Secty.	知情卖出	10,000	$80.00	$800K	12,365
2021-07-26	Tombesi Paolo	Officer	未知	-	-	-	-
2021-07-26	Tombesi Paolo	EVP & Chief Financial Officer	限制性股票授予 (RSU)	13,600	-	-	13,600
2021-07-14	Partridge Andrew John	EVP & Chief Commercial Officer	知情卖出	1,869	$74.90	$139.99K	21,767
2021-06-21	Alles Mark J	Director	知情买入	2,000	$81.34	$162.68K	2,000
2021-06-15	North Annette	EVP, General Counsel & Secty.	知情卖出	6,634	$77.82	$516.26K	12,365
2021-06-02	Machado Patrick	Director	限制性股票授予 (RSU)	8,500	$65.64	$557.94K	8,500
2021-06-02	Gallagher Carol Giltner	Director	限制性股票授予 (RSU)	8,500	$65.64	$557.94K	8,500
2021-06-02	Alles Mark J	Director	限制性股票授予 (RSU)	209	$65.64	$13.72K	209
2021-06-02	George Simeon	Director	限制性股票授予 (RSU)	8,500	$65.64	$557.94K	8,500
2021-06-02	Nicholson Garry A	Director	限制性股票授予 (RSU)	8,500	$65.64	$557.94K	8,500
2021-05-24	Alles Mark J	Director	未知	-	-	-	-
2021-05-24	Alles Mark J	Director	限制性股票授予 (RSU)	17,000	$70.60	$1.2M	17,000
2021-05-14	Van Hoose Kyri K.	Officer	未知	-	-	-	-
2021-05-06	North Annette	EVP, General Counsel & Secty.	期权行权	5,882	$17.00	$99.99K	12,365
2021-03-31	Bodem Barbara W.	Director	未知	-	-	-	-
2021-03-31	Bodem Barbara W.	Director	限制性股票授予 (RSU)	14,995	$94.59	$1.42M	14,995
2021-03-23	Baker Brian Lee	SVP of Finance and Admin.	期权行权（卖出）	1,298	$3.20	$4.15K	-
2021-03-22	Baker Brian Lee	SVP of Finance and Admin.	限制性股票授予 (RSU)	1,625	-	-	4,116
2021-03-08	North Annette	EVP, General Counsel & Secty.	知情卖出	700	$111.69	$78.18K	6,483
2021-03-04	Reich Siegfried	EVP & Chief Scientific Officer	知情卖出	600	$111.46	$66.88K	3,845
2021-02-11	Countouriotis Athena	President & CEO	知情卖出	3,052	$138.55	$422.85K	50,195
2021-02-10	Countouriotis Athena	President & CEO	知情卖出	433	$138.19	$59.84K	50,195
2021-02-09	Countouriotis Athena	President & CEO	知情卖出	1,104	$140.24	$154.82K	50,195
2021-02-08	North Annette	EVP, General Counsel & Secty.	限制性股票授予 (RSU)	6,483	-	-	6,483
2021-02-08	Reich Siegfried	EVP & Chief Scientific Officer	限制性股票授予 (RSU)	3,845	-	-	3,845
2021-02-08	Countouriotis Athena	President & CEO	限制性股票授予 (RSU)	22,617	-	-	50,195
2021-02-08	Hirmand Mohammad	EVP and Chief Medical Officer	限制性股票授予 (RSU)	6,483	-	-	6,767